Journal article
Predicting modafinil-treatment response in poststroke fatigue using brain morphometry and functional connectivity
MM Visser, B Maréchal, P Goodin, TP Lillicrap, C Garcia-Esperon, NJ Spratt, MW Parsons, CR Levi, A Bivard
Stroke | LIPPINCOTT WILLIAMS & WILKINS | Published : 2019
Abstract
Background and Purpose - Poststroke fatigue affects a large proportion of stroke survivors and is associated with a poor quality of life. In a recent trial, modafinil was shown to be an effective agent in reducing poststroke fatigue; however, not all patients reported a significant decrease in fatigue with therapy. We sought to investigate clinical and radiological predictors of fatigue reduction with modafinil therapy in a stroke survivor cohort. Methods - Twenty-six participants with severe fatigue (multidimensional fatigue inventory-20 ≥60) underwent magnetic resonance imaging at baseline and during the last week of a 6-week treatment period of 200 mg modafinil taken daily. Resting-state ..
View full abstractGrants
Funding Acknowledgements
This study was funded externally with a Seed Grant by the National Stroke Foundation of Australia. Dr Spratt was recipient of a Cofunded National Health and Medical Research Council/National Heart Foundation Career Development/Future Leader Fellowship APP1110629/100827.